BMSSC
GILD icon

B. Metzler seel. Sohn & Co’s Gilead Sciences GILD Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.3M Sell
102,768
-4,941
-5% -$692K 0.13% 93
2025
Q4 		$13.2M Buy
107,709
+17,584
+20% +$2.14M 0.12% 98
2025
Q3 		$10M Sell
90,125
-8,102
-8% -$921K 0.09% 118
2025
Q2 		$10.9M Buy
98,227
+3,367
+4% +$358K 0.1% 100
2025
Q1 		$10.6M Buy
94,860
+12,265
+15% +$1.27M 0.11% 96
2024
Q4 		$7.63M Sell
82,595
-30,906
-27% -$2.78M 0.08% 117
2024
Q3 		$9.52M Sell
113,501
-2,476
-2% -$189K 0.09% 117
2024
Q2 		$7.96M Sell
115,977
-1,167
-1% -$77.9K 0.08% 124
2024
Q1 		$8.58M Buy
117,144
+6,683
+6% +$514K 0.09% 117
2023
Q4 		$8.95M Sell
110,461
-3,303
-3% -$257K 0.11% 104
2023
Q3 		$8.52M Buy
113,764
+20,670
+22% +$1.59M 0.13% 99
2023
Q2 		$7.17M Buy
93,094
+1,425
+2% +$114K 0.1% 142
2023
Q1 		$7.61M Sell
91,669
-12,892
-12% -$1.07M 0.12% 118
2022
Q4 		$8.98M Sell
104,561
-21,057
-17% -$1.67M 0.15% 103
2022
Q3 		$7.75M Buy
125,618
+17,816
+17% +$1.12M 0.14% 108
2022
Q2 		$6.66M Sell
107,802
-25,464
-19% -$1.58M 0.11% 131
2022
Q1 		$7.92M Buy
133,266
+12,266
+10% +$784K 0.11% 132
2021
Q4 		$8.88M Buy
121,000
+50,955
+73% +$3.51M 0.12% 121
2021
Q3 		$4.89M Buy
70,045
+5,791
+9% +$407K 0.07% 167
2021
Q2 		$4.42M Sell
64,254
-19,996
-24% -$1.34M 0.07% 163
2021
Q1 		$5.44M Sell
84,250
-6,487
-7% -$418K 0.09% 144
2020
Q4 		$5.37M Buy
+90,737
New +$5.48M 0.1% 130

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

B. Metzler seel. Sohn & Co's GILD Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co reduced its Gilead Sciences (GILD) stake by 4.6% in Q1 2026, selling an estimated $692K and leaving 102,768 shares worth $14.3M. The position accounts for 0.13% of the portfolio, ranked #93.

B. Metzler seel. Sohn & Co first reported a position in GILD in Q4 2020 and has held it in 22 quarters since. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • B. Metzler seel. Sohn & Co held 102,768 shares of Gilead Sciences worth $14.3M as of Q1 2026.
  • B. Metzler seel. Sohn & Co sold 4,941 Gilead Sciences shares in Q1 2026, an estimated $692K.
  • Gilead Sciences made up 0.13% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #93 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Gilead Sciences in Q4 2020 and has held it in 22 quarters since.
  • 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.